# Tenax Therapeutics (TENX) — Analyst Forecast

TENX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/tenx/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 7 | 3 | 0 | 10 |

## Price target

| Low | Average | High | Analysts |
| --- | --- | --- | --- |
| $4.00 | $10.60 | $35.00 | 5 |

Last price $1.51 (as of Oct 16, 2026).

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Aug 31, 2026 | Guggenheim | Downgraded | Buy → Neutral | — |
| Aug 11, 2026 | Evercore ISI Group | Downgraded | Outperform → In-Line | $5.00 |
| Aug 11, 2026 | Guggenheim | Maintained | Buy | $4.00 |
| Aug 11, 2026 | Canaccord Genuity | Maintained | Buy | $4.00 |
| Aug 11, 2026 | Chardan Capital | Downgraded | Buy → Neutral | $5.00 |
| Aug 10, 2026 | William Blair | Downgraded | Outperform → Market Perform | — |
| Jul 31, 2026 | Chardan Capital | Maintained | Buy | $27.00 |
| Jul 29, 2026 | Cantor Fitzgerald | Maintained | Overweight | $35.00 |
| Jul 28, 2026 | Canaccord Genuity | Initiated Coverage | Buy | $35.00 |
| Jul 22, 2026 | Evercore ISI Group | Initiated Coverage | Outperform | $39.00 |
| Jul 2, 2026 | Chardan Capital | Maintained | Buy | $27.00 |
| Jun 24, 2026 | Cantor Fitzgerald | Maintained | Overweight | $35.00 |
| Jun 22, 2026 | Guggenheim | Maintained | Buy | $40.00 |
| Jun 22, 2026 | Chardan Capital | Initiated Coverage | Buy | $27.00 |
| Jun 12, 2026 | Piper Sandler | Maintained | Overweight | $50.00 |
| Mar 17, 2026 | Cantor Fitzgerald | Initiated Coverage | Overweight | $35.00 |
| Mar 16, 2026 | Guggenheim | Maintained | Buy | $34.00 |
| Dec 17, 2025 | Guggenheim | Maintained | Buy | $25.00 |
| Sep 8, 2025 | Piper Sandler | Initiated Coverage | Overweight | $20.00 |
| Aug 14, 2025 | Guggenheim | Maintained | Buy | $14.00 |

## Frequently Asked Questions

### What is the price target for TENX stock?

The average 12-month analyst price target for Tenax Therapeutics (TENX) is $10.60, with a high estimate of $35.00 and a low of $4.00, across 5 analysts.

### Is TENX a buy, sell, or hold?

Analysts covering Tenax Therapeutics currently average a Buy rating: 7 buy, 3 hold and 0 sell, from 10 analysts. Ratings reflect analyst opinion, not investment advice.

### What upside do analysts see for TENX?

The average price target of $10.60 implies 601.99% upside from the last price of $1.51.

### What is the latest analyst rating on TENX?

On Aug 31, 2026, Guggenheim downgraded Tenax Therapeutics to Neutral.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).